US5234767A
(en)
*
|
1987-03-13 |
1993-08-10 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
JP2617346B2
(ja)
*
|
1987-03-13 |
1997-06-04 |
マイクロ ベシキュラー システムズ,インコーポレイテッド |
表面活性剤とステロイドから形成される脂質小胞
|
US5474848A
(en)
*
|
1987-03-13 |
1995-12-12 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5147723A
(en)
*
|
1987-07-28 |
1992-09-15 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5628936A
(en)
*
|
1987-03-13 |
1997-05-13 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
US5219538A
(en)
*
|
1987-03-13 |
1993-06-15 |
Micro-Pak, Inc. |
Gas and oxygen carrying lipid vesicles
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
EP0324455A3
(de)
*
|
1988-01-15 |
1991-03-27 |
Hans O. Ribi |
Neue polymerische Immuno-Adjuvans
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
US5019174A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro Vesicular Systems, Inc. |
Removing oil from surfaces with liposomal cleaner
|
US5104736A
(en)
*
|
1988-03-03 |
1992-04-14 |
Micro-Pak, Inc. |
Reinforced paucilamellar lipid vesicles
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5032457A
(en)
*
|
1988-03-03 |
1991-07-16 |
Micro Vesicular Systems, Inc. |
Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5510117A
(en)
*
|
1989-03-09 |
1996-04-23 |
Micro-Pak, Inc. |
Entrapment vehicle and method
|
GB8906234D0
(en)
*
|
1989-03-17 |
1989-05-04 |
Albright & Wilson |
Agrochemical suspensions
|
AU6524990A
(en)
*
|
1989-09-21 |
1991-04-18 |
Micro Vesicular Systems, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
FR2657607B1
(fr)
*
|
1990-01-30 |
1992-04-30 |
Durand Muriel |
Procede de protection de la dihydroxyacetone, dihydroxyacetone protegee par ce procede et produit cosmetique contenant une telle dihydroxyacetone protegee.
|
US5213810A
(en)
*
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5165994A
(en)
*
|
1990-06-05 |
1992-11-24 |
University Of Delaware |
Spontaneous equilbrium surfactant vesicles
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US6165500A
(en)
*
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
WO1992003123A1
(en)
*
|
1990-08-28 |
1992-03-05 |
Liposome Technology, Inc. |
Liposome alternative bilayer formulations
|
DK0550463T3
(da)
*
|
1990-09-06 |
1996-11-04 |
Johnson & Son Inc S C |
Fremgangsmåde til stabilisering af liposomer samt sammensætninger indeholdende dem
|
US5091111A
(en)
*
|
1990-09-19 |
1992-02-25 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aersol delivery system using same
|
US5145604A
(en)
*
|
1990-09-19 |
1992-09-08 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aerosol delivery system using same
|
US5256422A
(en)
*
|
1991-03-28 |
1993-10-26 |
Micro Vesicular Systems, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
DE69227580T2
(de)
*
|
1991-03-28 |
1999-04-08 |
Micro Pak Inc |
Wasser-in-öl-emulsionen, die lipidvesikel enthalten
|
DE4121945C2
(de)
*
|
1991-07-03 |
1993-11-04 |
Merz & Co Gmbh & Co |
Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung
|
US5213805A
(en)
*
|
1991-07-25 |
1993-05-25 |
Micro Vesicular Systems, Inc. |
Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
|
US5405615A
(en)
*
|
1991-09-17 |
1995-04-11 |
Micro Vesicular Systems, Inc. |
Sucrose distearate lipid vesicles
|
US5260065A
(en)
*
|
1991-09-17 |
1993-11-09 |
Micro Vesicular Systems, Inc. |
Blended lipid vesicles
|
US5643600A
(en)
*
|
1991-09-17 |
1997-07-01 |
Micro-Pak, Inc. |
Lipid vesicles containing avocado oil unsaponifiables
|
US5439967A
(en)
*
|
1991-09-17 |
1995-08-08 |
Micro Vesicular Systems, Inc. |
Propylene glycol stearate vesicles
|
CA2150463A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Donald F. H. Wallach |
Extended duration antacid product
|
US5393527A
(en)
*
|
1993-01-04 |
1995-02-28 |
Becton, Dickinson And Company |
Stabilized microspheres and methods of preparation
|
WO1994016061A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Micro Vesicular Systems, Inc. |
Method of inhibiting viral reproduction
|
US5853755A
(en)
*
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
DE69435244D1
(de)
*
|
1993-12-17 |
2009-11-26 |
Novavax Inc |
Verfahren zur übertragung eines biologisch aktiven materials an eine zelle
|
BR9506885A
(pt)
*
|
1994-02-24 |
1997-08-19 |
Micro Pak Inc |
Vacinas contendo vesículas de lipidio paucilamelares como adjuvantes imunológicos
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
US5629021A
(en)
*
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
FR2730928B1
(fr)
*
|
1995-02-23 |
1997-04-04 |
Oreal |
Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
|
US5599548A
(en)
*
|
1995-05-08 |
1997-02-04 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing fatty acid amides and retinol or retinyl ester
|
US5954998A
(en)
*
|
1995-05-25 |
1999-09-21 |
The Clorox Company |
Liquid peracid precursor colloidal dispersions: oil-core vesicles
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US5834014A
(en)
*
|
1995-10-06 |
1998-11-10 |
The Regents Of The University Of Michigan |
Stimulation of hair follicles
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US5662957A
(en)
*
|
1996-05-03 |
1997-09-02 |
Novavax, Inc. |
Oil containing lipid vesicles with marine applications
|
US5700679A
(en)
*
|
1996-06-07 |
1997-12-23 |
Novavax, Inc. |
Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
|
US5846551A
(en)
*
|
1996-06-10 |
1998-12-08 |
E-L Management Corp. |
Water-based makeup compositions and methods for their preparation
|
US5955092A
(en)
*
|
1996-09-27 |
1999-09-21 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
|
US5747051A
(en)
*
|
1996-09-27 |
1998-05-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6039960A
(en)
*
|
1997-05-28 |
2000-03-21 |
E-L Management Corp. |
Water containing wax-based product
|
IS4518A
(is)
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US5993852A
(en)
*
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
TW476788B
(en)
|
1998-04-08 |
2002-02-21 |
Kimberly Clark Co |
A cleanser and the making process thereof
|
GB9824024D0
(en)
*
|
1998-11-03 |
1998-12-30 |
Unilever Plc |
Shampoo compositions
|
PL193824B1
(pl)
*
|
1998-12-23 |
2007-03-30 |
Idea Ag |
Preparat zawierający środki penetrujące, sposób wytwarzania preparatu zawierającego środki penetrujące oraz zastosowanie preparatu do wytwarzania leku
|
SI1031347T1
(en)
|
1999-01-27 |
2002-10-31 |
Idea Ag |
Transnasal transport/immunisation with highly adaptable carriers
|
ES2173678T3
(es)
|
1999-01-27 |
2002-10-16 |
Idea Ag |
Vacunacion no invasiva a traves de la piel.
|
US6080211A
(en)
|
1999-02-19 |
2000-06-27 |
Igen, Inc. |
Lipid vesicle-based fuel additives and liquid energy sources containing same
|
CA2309373A1
(en)
*
|
1999-05-27 |
2000-11-27 |
Johnson & Johnson Consumer Companies, Inc. |
Novel topical formulations
|
AU5409699A
(en)
*
|
1999-07-05 |
2001-01-22 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers
|
US6309664B1
(en)
|
1999-09-15 |
2001-10-30 |
Igen, Incorporated |
Methods, uses and compositions of fluid petrolatum
|
US6534078B1
(en)
*
|
1999-10-18 |
2003-03-18 |
Natural Pest Fx, Inc. |
Micro-encapsulated pepper-mustard composition and methods of using the same
|
US6375968B1
(en)
|
1999-10-22 |
2002-04-23 |
3M Innovative Properties Company |
Encapsulated active material immobilized in hydrogel microbeads
|
US6376514B1
(en)
|
2000-10-17 |
2002-04-23 |
The Procter & Gamble Co. |
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
|
US6540991B2
(en)
|
2001-04-06 |
2003-04-01 |
3M Innovative Properties Company |
Stabilized active materials
|
US6562361B2
(en)
|
2001-05-02 |
2003-05-13 |
3M Innovative Properties Company |
Pheromone immobilized in stable hydrogel microbeads
|
US20030129180A1
(en)
*
|
2001-08-01 |
2003-07-10 |
The Proctor & Gamble Company |
Products and methods for treating microbial infections
|
JP2005509598A
(ja)
*
|
2001-08-16 |
2005-04-14 |
リュフヤトルン・エイチエフ,バイオファーマシューティカルズ |
エクスビボで抗体を産生する方法
|
US6709663B2
(en)
|
2001-08-31 |
2004-03-23 |
Healthpoint, Ltd. |
Multivesicular emulsion drug delivery systems
|
DE60137229D1
(de)
*
|
2001-10-22 |
2009-02-12 |
Viroblock Sa |
Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
|
US20030129213A1
(en)
*
|
2001-12-26 |
2003-07-10 |
Gonzalez Anthony D. |
Meta-stable insect repellent emulsion composition and method of use
|
US20030219465A1
(en)
*
|
2002-05-23 |
2003-11-27 |
Suresh Kumar Gidwani |
Composition for delivery of dithranol
|
US20030232091A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Adi Shefer |
Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
|
US7473432B2
(en)
*
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
EP2314595A3
(de)
*
|
2003-09-29 |
2011-07-20 |
Topigen Pharmaceuticals Inc. |
Oligonukleotid-Zusammensetzungen und Verfahren zur Behandlung von Augenerkrankungen und -leiden
|
CA2708437C
(en)
*
|
2004-04-05 |
2013-05-14 |
Kanagawa University |
Emulsification dispersants, a method for emulsification and dispersion using the emulsification dispersants, emulsions, and emulsion fuels
|
US8034796B2
(en)
*
|
2004-04-07 |
2011-10-11 |
The University Of Georgia Research Foundation, Inc. |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
EA200601648A1
(ru)
|
2004-04-07 |
2007-04-27 |
Зе Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. |
Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы
|
JP4616602B2
(ja)
*
|
2004-09-16 |
2011-01-19 |
大日本塗料株式会社 |
単分散粒子の製造方法
|
ES2450929T3
(es)
|
2004-10-29 |
2014-03-25 |
Topigen Pharmaceuticals Inc. |
Oligonucleótidos antisentido para tratar la alergia y la proliferación de las células neoplásicas
|
EP1811961A2
(de)
*
|
2004-11-12 |
2007-08-01 |
Idea Ag |
Erweiterte oberflächen-aggregate bei der behandlung von hauterkrankungen
|
JP4533420B2
(ja)
*
|
2004-12-22 |
2010-09-01 |
日東電工株式会社 |
線維化抑制のための薬物担体および薬物担体キット
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
SI2727583T1
(sl)
*
|
2004-12-22 |
2022-01-31 |
Nitto Denko Corporation |
Nosilec učinkovine in komplet nosilca učinkovine za zaviranje fibroze
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
US8449979B2
(en)
*
|
2005-01-28 |
2013-05-28 |
Japan Science And Technology Agency |
Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
|
ES2580108T3
(es)
|
2005-07-11 |
2016-08-19 |
Aerie Pharmaceuticals, Inc |
Compuestos de isoquinolina
|
EP1951762B1
(de)
*
|
2005-10-03 |
2018-02-07 |
PINSKY, Mark A. |
Zusammensetzungen und verfahren zur verbesserten hautpflege
|
RU2483751C2
(ru)
|
2005-10-18 |
2013-06-10 |
Новавакс, Инк. |
ФУНКЦИОНАЛЬНЫЕ ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ ГРИППА (VLPs)
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
CN101448486B
(zh)
*
|
2006-05-19 |
2012-10-31 |
凡罗布洛克公司 |
一种用于灭活包膜病毒的组合物
|
JP2009537118A
(ja)
*
|
2006-05-19 |
2009-10-29 |
トピジェン・ファーマシューティカルズ・インコーポレーテッド |
ホスホジエステラーゼの発現に影響するオリゴヌクレオチド
|
WO2008036540A2
(en)
|
2006-09-20 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
JP5512280B2
(ja)
*
|
2006-12-28 |
2014-06-04 |
スリーエム イノベイティブ プロパティズ カンパニー |
歯科充填剤及び方法
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
EP2111215A4
(de)
*
|
2007-01-18 |
2013-03-06 |
Mark A Pinsky |
Materialien und verfahren zur verabreichung von antioxidantien in die haut
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
EP2190448B1
(de)
|
2007-06-22 |
2016-04-20 |
Children's Medical Center Corporation |
Verfahren und verwendung eines fragments des saposin a
|
FR2917976B1
(fr)
*
|
2007-06-29 |
2010-05-28 |
Galderma Sa |
Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
|
EP2175883A4
(de)
|
2007-07-19 |
2011-11-30 |
Novavax Inc |
Chimäre varicella zoster virus-virusähnliche partikel
|
EP2222270B1
(de)
*
|
2007-12-26 |
2018-11-14 |
Mark A. Pinsky |
Collagenformulierungen für verbesserte hautpflege
|
US8455514B2
(en)
*
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
US10251839B2
(en)
*
|
2008-01-22 |
2019-04-09 |
Igi Laboratories, Inc. |
Lipid vesicles derived from olive oil fatty acids
|
JP2011519579A
(ja)
|
2008-05-15 |
2011-07-14 |
トピジェン ファーマスーティカルズ インク |
炎症および新生細胞増殖の治療のためのオリゴヌクレオチド
|
EP2294178B1
(de)
|
2008-05-23 |
2014-07-16 |
Siwa Corporation |
Verfahren zur regenerationserleichterung
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
JP2012509932A
(ja)
*
|
2008-11-26 |
2012-04-26 |
ビロブロック エスアー |
非リン脂質脂質小胞を使用してグラム陽性菌を抑制する方法
|
WO2010077717A1
(en)
|
2008-12-09 |
2010-07-08 |
Novavax, Inc. |
Modified rsv f proteins and methods of their use
|
JP2012525386A
(ja)
|
2009-05-01 |
2012-10-22 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
疾患の治療のための二重機構阻害剤
|
EP3871671A3
(de)
|
2009-07-29 |
2022-03-09 |
Olsen, Elise |
Fp rezeptorantagonisten zur hemmung von haarwachstum
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
US20110070293A1
(en)
*
|
2009-09-23 |
2011-03-24 |
Javeri Indu |
Methods for the Preparation of Liposomes Comprising Docetaxel
|
AU2010339794B2
(en)
|
2009-12-17 |
2016-09-22 |
Children's Medical Center Corporation |
Saposin-A derived peptides and uses thereof
|
WO2012047629A2
(en)
|
2010-09-27 |
2012-04-12 |
Siwa Corporation |
Selective removal of age-modified cells for treatment of ather0sclerosis
|
CN109157658A
(zh)
|
2010-11-05 |
2019-01-08 |
诺瓦瓦克斯股份有限公司 |
狂犬病糖蛋白病毒样颗粒(vlp)
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
EP2646107A2
(de)
|
2010-12-01 |
2013-10-09 |
Spinal Modulation Inc. |
Wirkstofffreisetzungssysteme für selektive nervenmodulation
|
US9260519B2
(en)
|
2011-06-17 |
2016-02-16 |
President And Fellows Of Harvard College |
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
|
CA2877102C
(en)
|
2011-06-29 |
2020-06-30 |
Avidas Pharmaceuticals Llc |
Topical formulations including lipid microcapsule delivery vehicles and their uses
|
CA2853829C
(en)
|
2011-07-22 |
2023-09-26 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
EP3560509B1
(de)
|
2011-12-22 |
2024-01-31 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
WO2013119602A1
(en)
|
2012-02-06 |
2013-08-15 |
President And Fellows Of Harvard College |
Arrdc1-mediated microvesicles (armms) and uses thereof
|
JP6492003B2
(ja)
|
2012-03-30 |
2019-03-27 |
ワシントン・ユニバーシティWashington University |
発作を減少させるためおよび神経変性症候群を改質するためにタウ発現を調節する方法
|
CN111254145A
(zh)
|
2013-03-14 |
2020-06-09 |
Ionis制药公司 |
用于调节tau表达的组合物和方法
|
PT3811943T
(pt)
|
2013-03-15 |
2023-03-15 |
Aerie Pharmaceuticals Inc |
Composto para uso no tratamento de distúrbios oculares
|
US10376562B2
(en)
|
2013-03-15 |
2019-08-13 |
The Jackson Laboratory |
Methods for promoting wound healing and hair growth comprising GDNF administration
|
US20140325490A1
(en)
*
|
2013-04-25 |
2014-10-30 |
Hewlett-Packard Development Company, L.P. |
Classifying Source Code Using an Expertise Model
|
TW202246503A
(zh)
|
2013-07-19 |
2022-12-01 |
美商百健Ma公司 |
用於調節τ蛋白表現之組合物
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
MX2016003419A
(es)
|
2013-09-19 |
2016-10-10 |
Novavax Inc |
Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
|
US20150166982A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting pi3k point mutations
|
MX2016008352A
(es)
*
|
2013-12-23 |
2017-01-12 |
Dermopartners S L |
Procedimiento de preparacion de liposomas de retinaldehido u otros precursores del acido retinoico y producto asi obtenido.
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
MY192824A
(en)
|
2014-09-03 |
2022-09-12 |
Boehringer Ingelheim Int |
Compound targeting il-23a and tnf-alpha and uses thereof
|
BR112017005517A2
(pt)
|
2014-09-19 |
2017-12-05 |
Siwa Corp |
anticorpos antiage para o tratamento de inflama-ção e de transtornos autoimunes
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
US10487324B2
(en)
|
2015-02-25 |
2019-11-26 |
Washington University |
Methods to detect motor neuron disease comprising micro-RNAs
|
EP3322436A4
(de)
|
2015-07-23 |
2019-03-27 |
Boehringer Ingelheim International GmbH |
Auf il-23-a- und -b-zellaktivierungsfaktor (baff) abzielende verbindung und verwendungen davon
|
IL257800B2
(en)
|
2015-09-03 |
2023-11-01 |
Novavax Inc |
Immune compositions with improved stability and immunogenicity
|
JP2018535953A
(ja)
|
2015-10-13 |
2018-12-06 |
シワ コーポレーション |
抗age抗体およびその使用方法
|
EP4269577A3
(de)
|
2015-10-23 |
2024-01-17 |
President and Fellows of Harvard College |
Nukleobaseeditoren und deren verwendungen
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
JP6832946B2
(ja)
|
2015-11-17 |
2021-02-24 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤およびその中間体の調製方法
|
EP3337829B1
(de)
|
2016-02-19 |
2020-01-08 |
Siwa Corporation |
Verfahren und zusammensetzung zur behandlung von krebs, abtötung von metastasierenden krebszellen und verhinderung von krebsmetastasen mit einem antikörper gegen fortgeschrittene glykierungsendprodukte
|
US10435682B2
(en)
|
2016-02-19 |
2019-10-08 |
University Of South Florida |
Arginine deiminase gene therapy for disordered proteins
|
WO2017181116A1
(en)
|
2016-04-15 |
2017-10-19 |
Siwa Corporation |
Anti-age antibodies for treating neurodegenerative disorders
|
AU2017277905B2
(en)
|
2016-06-08 |
2022-04-14 |
Children's Medical Center Corporation |
Engineered Botulinum neurotoxins
|
US11213585B2
(en)
|
2016-06-23 |
2022-01-04 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
FI3481852T3
(fi)
|
2016-07-08 |
2023-03-19 |
Childrens Medical Center |
Uusi botulinum-neurotoksiini ja sen johdannaisia
|
SG11201900907YA
(en)
|
2016-08-03 |
2019-02-27 |
Harvard College |
Adenosine nucleobase editors and uses thereof
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
CN106268551B
(zh)
*
|
2016-08-09 |
2018-11-20 |
中国石油大学(华东) |
一种具有光捕获功能的多级复合微胶囊的制备方法
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
KR102568079B1
(ko)
|
2016-08-31 |
2023-08-17 |
에어리 파마슈티컬즈, 인코포레이티드 |
안과용 조성물
|
JOP20190065A1
(ar)
|
2016-09-29 |
2019-03-28 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن tau
|
US11730823B2
(en)
|
2016-10-03 |
2023-08-22 |
President And Fellows Of Harvard College |
Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
|
CN110214180A
(zh)
|
2016-10-14 |
2019-09-06 |
哈佛大学的校长及成员们 |
核碱基编辑器的aav递送
|
JP7456605B2
(ja)
|
2016-12-23 |
2024-03-27 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Pcsk9の遺伝子編集
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
CN110662556A
(zh)
|
2017-03-09 |
2020-01-07 |
哈佛大学的校长及成员们 |
癌症疫苗
|
EP3592777A1
(de)
|
2017-03-10 |
2020-01-15 |
President and Fellows of Harvard College |
Cytosin-zu-guanin-baseneditor
|
CN110914426A
(zh)
|
2017-03-23 |
2020-03-24 |
哈佛大学的校长及成员们 |
包含核酸可编程dna结合蛋白的核碱基编辑器
|
MX2019011784A
(es)
|
2017-03-31 |
2019-11-18 |
Aerie Pharmaceuticals Inc |
Compuestos de aril ciclopropil-amino-isoquinolinil amida.
|
EP3609923A1
(de)
|
2017-04-13 |
2020-02-19 |
Siwa Corporation |
Humanisierter monoklonaler advanced-glycation-endproduct-antikörper
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
US20210137845A1
(en)
|
2017-07-24 |
2021-05-13 |
Novavax, Inc. |
Methods and compositions for treating respiratory disease
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
WO2019067815A2
(en)
|
2017-09-29 |
2019-04-04 |
Children's Medical Center Corporation |
NEUROTOXIN-LIKE TOXIN AND USES THEREOF
|
JP2021500036A
(ja)
|
2017-10-16 |
2021-01-07 |
ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. |
アデノシン塩基編集因子の使用
|
WO2019113210A1
(en)
|
2017-12-05 |
2019-06-13 |
Anthos Partners, Lp |
Phosphonium-based ionic drug conjugates
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
US11254704B2
(en)
|
2018-01-05 |
2022-02-22 |
University Of South Florida |
Compounds and methods for reducing or inhibiting aggregation of proteins in a subject
|
US20220307001A1
(en)
|
2018-02-27 |
2022-09-29 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
US10507226B1
(en)
|
2018-05-02 |
2019-12-17 |
University Of South Florida |
N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
|
CA3100034A1
(en)
|
2018-05-11 |
2019-11-14 |
Beam Therapeutics Inc. |
Methods of editing single nucleotide polymorphism using programmable base editor systems
|
EP3797160A1
(de)
|
2018-05-23 |
2021-03-31 |
The Broad Institute Inc. |
Baseneditoren und verwendungen davon
|
EP3826670A1
(de)
|
2018-07-23 |
2021-06-02 |
Siwa Corporation |
Verfahren und zusammensetzungen zur behandlung chronischer effekte von strahlung und chemischer exposition
|
WO2020051360A1
(en)
|
2018-09-05 |
2020-03-12 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
AU2019337703B2
(en)
|
2018-09-14 |
2023-02-02 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
WO2020102659A1
(en)
|
2018-11-15 |
2020-05-22 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
US20220170013A1
(en)
|
2019-03-06 |
2022-06-02 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
BR112021018607A2
(pt)
|
2019-03-19 |
2021-11-23 |
Massachusetts Inst Technology |
Métodos e composições para editar sequências de nucleotídeos
|
US20220204975A1
(en)
|
2019-04-12 |
2022-06-30 |
President And Fellows Of Harvard College |
System for genome editing
|
EP3956349A1
(de)
|
2019-04-17 |
2022-02-23 |
The Broad Institute, Inc. |
Adeninbaseneditoren mit reduzierten off-target-effekten
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
US20220315906A1
(en)
|
2019-08-08 |
2022-10-06 |
The Broad Institute, Inc. |
Base editors with diversified targeting scope
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
WO2021050512A1
(en)
|
2019-09-09 |
2021-03-18 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
WO2021072328A1
(en)
|
2019-10-10 |
2021-04-15 |
The Broad Institute, Inc. |
Methods and compositions for prime editing rna
|
WO2021108717A2
(en)
|
2019-11-26 |
2021-06-03 |
The Broad Institute, Inc |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
CN114981426A
(zh)
|
2019-12-03 |
2022-08-30 |
比姆医疗股份有限公司 |
合成向导rna、其组合物、方法和用途
|
CA3166153A1
(en)
|
2020-01-28 |
2021-08-05 |
The Broad Institute, Inc. |
Base editors, compositions, and methods for modifying the mitochondrial genome
|
WO2021158999A1
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
EP4100519A2
(de)
|
2020-02-05 |
2022-12-14 |
The Broad Institute, Inc. |
Adeninbaseneditoren und verwendungen davon
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
IL297799A
(en)
|
2020-05-01 |
2022-12-01 |
Siwa Corp |
Methods for treating infections
|
CN116096873A
(zh)
|
2020-05-08 |
2023-05-09 |
布罗德研究所股份有限公司 |
同时编辑靶标双链核苷酸序列的两条链的方法和组合物
|
WO2022093195A1
(en)
|
2020-10-27 |
2022-05-05 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
|
EP4237556A2
(de)
|
2020-10-28 |
2023-09-06 |
Children's Medical Center Corporation |
Verkürztes modifiziertes rekombinantes adamts13 und verwendungen davon
|
US20240000930A1
(en)
|
2020-12-09 |
2024-01-04 |
Siwa Corporation |
Methods and compositions for treating kidney diseases
|
US20220290164A1
(en)
|
2021-02-19 |
2022-09-15 |
Beam Therapeutics Inc, |
Recombinant rabies viruses for gene therapy
|
US20240167008A1
(en)
|
2021-03-23 |
2024-05-23 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
JP2024514649A
(ja)
|
2021-04-16 |
2024-04-02 |
ビーム セラピューティクス インク. |
肝細胞の遺伝子修飾
|
AU2022285744A1
(en)
|
2021-06-02 |
2023-12-14 |
Beam Therapeutics Inc. |
Circular guide rnas for crispr/cas editing systems
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
EP4373931A1
(de)
|
2021-07-23 |
2024-05-29 |
Beam Therapeutics Inc. |
Guide-rnas für crispr/cas-editiersysteme
|
WO2023023654A1
(en)
|
2021-08-20 |
2023-02-23 |
Siwa Corporation |
Methods and compositions for treating fibrotic diseases
|
AU2022343725A1
(en)
|
2021-09-08 |
2024-03-21 |
Beam Therapeutics Inc. |
Viral guide rna delivery
|
WO2023076898A1
(en)
|
2021-10-25 |
2023-05-04 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
CA3238700A1
(en)
|
2021-11-23 |
2022-11-23 |
Philippe Duchateau |
New tale protein scaffolds with improved on-target/off-target activity ratios
|
CA3239498A1
(en)
|
2021-12-03 |
2023-06-08 |
David R. Liu |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
CA3238778A1
(en)
|
2021-12-03 |
2023-06-08 |
David R. Liu |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
CA3240917A1
(en)
|
2021-12-17 |
2023-06-22 |
Bernd ZETSCHE |
Crispr enzymes, methzods, systems and uses thereof
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023196772A1
(en)
|
2022-04-04 |
2023-10-12 |
Beam Therapeutics Inc. |
Novel rna base editing compositions, systems, methods and uses thereof
|
WO2023205687A1
(en)
|
2022-04-20 |
2023-10-26 |
The Broad Institute, Inc. |
Improved prime editing methods and compositions
|
WO2023212715A1
(en)
|
2022-04-28 |
2023-11-02 |
The Broad Institute, Inc. |
Aav vectors encoding base editors and uses thereof
|
WO2023230613A1
(en)
|
2022-05-27 |
2023-11-30 |
The Broad Institute, Inc. |
Improved mitochondrial base editors and methods for editing mitochondrial dna
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024059791A1
(en)
|
2022-09-16 |
2024-03-21 |
Beam Therapeutics Inc. |
Large serine recombinases, systems and uses thereof
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
WO2024102157A1
(en)
|
2022-11-09 |
2024-05-16 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|